启迪药业 (000590.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(启迪药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 69,577,822.2369,559,816.0177,093,552.53130,018,072.5784,579,135.0188,850,817.19101,199,883.45
 营业收入(元) 69,577,822.2369,559,816.0177,093,552.53130,018,072.5784,579,135.0188,850,817.19101,199,883.45
二、营业总成本(元) 76,893,248.4882,592,374.0485,671,039.65124,238,251.9784,961,822.2088,758,806.5794,851,970.71
 营业成本(元) 39,040,354.1739,321,653.4137,951,524.3962,316,618.7941,962,578.7440,969,873.2547,280,009.71
 研发费用(元) 3,030,717.894,161,509.942,533,019.903,566,733.773,159,690.363,058,174.543,035,083.94
 营业税金及附加(元) 1,543,722.032,177,805.541,819,441.972,474,103.222,029,515.332,079,075.212,142,172.64
 销售费用(元) 13,247,551.1915,098,047.7619,973,052.9325,057,127.8419,001,490.5422,833,006.5322,923,928.51
 管理费用(元) 19,416,944.2521,176,967.0522,844,054.0330,255,890.5118,288,852.7519,108,768.8119,162,287.67
 财务费用(元) 613,958.95656,390.34549,946.43567,777.84519,694.48709,908.23308,488.24
  其中:利息费用(元) 914,563.95968,834.73952,716.39966,263.611,061,724.081,383,304.211,051,034.62
  其中:利息收入(元) 315,868.62330,754.45418,234.27384,291.51499,164.32669,485.49686,959.78
 资产减值损失(元) -1,414.79------
 信用减值损失(元) 84,113.28-713,548.83826.80-7,801,159.21269,221.82-421,211.32-4,509.91
三、其他经营收益
 加:投资收益(元) 96,312.02-114,512.5889,950.70273,780.17150,834.20114,616.66346,628.90
 资产处置收益(元) -7,598.82--13,174,207.64-14,216.7519,432.91149,079.24
 其他收益(元) 2,185,899.80852,674.771,466,001.453,720,431.12486,724.52904,069.901,436,069.61
四、营业利润(元) -4,958,114.76-12,994,038.21-7,020,708.1710,665,723.71509,876.60708,918.778,275,180.58
 加:营业外收入(元) 14,766.017,200.098,716.509,707,551.053,360.0211,530.49840.64
 减:营业外支出(元) 122,144.36614,462.0156,967.71185,810.2715,569.54646.541,715.52
五、利润总额(元) -5,065,493.11-13,601,300.13-7,068,959.3820,187,464.49497,667.08719,802.728,274,305.70
 减:所得税费用(元) -108,478.741,408,648.301,197,529.201,874,524.88377,423.08871,297.191,665,795.09
六、净利润(元) -4,957,014.37-15,009,948.43-8,266,488.5818,312,939.61120,244.00-151,494.476,608,510.61
(一)按经营持续性分类
  持续经营净利润(元) -4,957,014.37-15,009,948.43-8,266,488.5818,312,939.61120,244.00-151,494.476,608,510.61
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -5,059,836.75-15,110,290.76-8,284,339.2818,816,628.9847,608.94-202,259.556,584,800.39
  少数股东损益(元) 102,822.38100,342.3317,850.70-503,689.3772,635.0650,765.0823,710.22
 扣除非经常性损益后的净利润(元) -7,494,855.86-15,028,880.10-9,360,105.58-7,658,780.29-540,861.35-1,433,463.154,982,651.04
七、每股收益
 一、基本每股收益(元) -0.02-0.06-0.030.08--0.03
 二、稀释每股收益(元) -0.02-0.06-0.030.08--0.03
九、综合收益总额(元) -4,957,014.37-15,009,948.43-8,266,488.5818,312,939.61120,244.00-151,494.476,608,510.61
 归属于母公司所有者的综合收益总额(元) -5,059,836.75-15,110,290.76-8,284,339.2818,816,628.9847,608.94-202,259.556,584,800.39
 归属于少数股东的综合收益总额(元) 102,822.38100,342.3317,850.70-503,689.3772,635.0650,765.0823,710.22
公告日期 2024-10-302024-08-292024-04-262024-03-282023-10-282023-08-232023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院